Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNMC.L Regulatory News (NMC)

  • There is currently no data for NMC

New O&M Contract

23 Aug 2017 07:15

RNS Number : 7128O
NMC Health Plc
23 August 2017
 

23 August 2017

 

NMC Health plc

(the "Company" or "NMC")

 

New O&M Contract

 

NMC Health plc (LSE:NMC), the leading integrated healthcare provider operating across the United Arab Emirates today announces it has signed a new O&M contract for the management of Emirates Healthcare assets, comprising three brands:

 

· Emirates Hospitals and Clinics: General medical services across six Emirates in the UAE

· CosmeSurge: Provider of cosmetic medical services in the UAE with 1 clinic in the UK

· Emirates Rehab and Homecare Services: Rehabilitation segment that provides home nursing, rehabilitation, therapeutic care and home-based care. Present in the UAE, Slovakia and Oman

 

NMC also recently extended the management contract for the 205 bed Sheikh Khalifa General Hospital in Umm Al Quwain (managed on behalf of the UAE Ministry of Presidential Affairs) for a further five years. The original contract was the first ever awarded by a Government Department to a local UAE business to manage a large Government healthcare facility, demonstrating confidence in NMC's significant healthcare experience and capabilities.

 

NMC is now managing multiple private and public sector healthcare facilities across varied geographies. Total annual revenues from the O&M vertical are set to reach USD $ 19m. These contracts continue to be associated with good returns and require minimal capital expenditure or working capital on part of the Group.

 

 

Enquiries:

 

NMC Health plc

Prasanth Manghat, Chief Executive Officer

+971 (0)50 522 5648

Suresh Krishnamoorthy, Chief Financial Officer

+971 (0)50 591 5365

Asjad Yahya, Investor Relations

 

Media:

FTI Consulting, London

Brett Pollard / Mo Noonan

+44 (0)20 3727 1100

 

FTI Consulting, Gulf

Shane Dolan

+971 (0)4 437 2100

 

 

About NMC Health

 

The NMC group (the "Group") is the leading private sector healthcare operator in the United Arab Emirates, with a nation-wide network of hospitals and operations in the country since 1975. The Group currently operates or manages eight hospitals, two day-care patient centres, nine medical centres and fifteen pharmacies. In addition, the Group owns and operates Clinica Eugin in Barcelona, Spain - one of the leading fertility treatment centres globally. NMC also owns a 51 per cent. shareholding in Fakih IVF Group, the Middle East market leader for in-vitro fertilisation ("IVF") services. Moreover, NMC also owns and operates Americare Group, the leading home care provider in the UAE as well as ProVita, the pioneering provider of long-term medical care, also in the UAE. The enlarged company received almost 4.3 million patients in 2016. The Group is also a leading UAE supplier of products and consumables across several key market segments, with the major contribution coming from healthcare related products. The Group reported revenues of US$1,220.8 million for the year ended 31 December 2016.

 

In April 2012 NMC was listed on the Premium Segment of the London Stock Exchange. NMC is a constituent of the FTSE 250 Index.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTPTMFTMBITBIR
Date   Source Headline
2nd Apr 20192:15 pmRNSExercise of Share Options
15th Mar 20192:49 pmRNSGrant of Options
15th Mar 20192:47 pmRNSGrant of Options
14th Mar 20192:21 pmRNSDirector/PDMR Shareholding
7th Mar 20197:00 amRNSFinancial Report: Full year ended 31 Dec 2018
5th Mar 20197:00 amRNSUpdate on KSA Joint Venture
20th Feb 20191:43 pmRNSNotice of Full Year Results
8th Feb 201912:00 pmRNSBoard Change
4th Feb 201912:00 pmRNSExercise of options
24th Jan 20191:44 pmRNSTR-1 Notification of Major Holdings
17th Jan 20193:33 pmRNSExercise of Options
27th Dec 201811:01 amRNSDirector/PDMR Shareholding
20th Dec 201812:53 pmRNSReplacement Director/PDMR Shareholding
20th Dec 201810:15 amRNSDirector/PDMR Shareholding
19th Dec 20183:59 pmRNSDirector/PDMR Shareholding
10th Dec 201811:05 amRNSDirector/PDMR Shareholding
10th Dec 201811:05 amRNSPurchase of Shares
10th Dec 20187:00 amRNSTrading Update
31st Oct 201812:25 pmRNSPurchase of Shares
24th Oct 20182:34 pmRNSBlock listing six monthly return
24th Oct 20182:34 pmRNSDirector/PDMR Shareholding
24th Oct 20182:34 pmRNSBlock listing six monthly return
22nd Oct 20187:00 amRNSCapital Markets Day & Positively Revised Guidance
29th Aug 201812:47 pmRNSAmended - Purchase of Shares
29th Aug 201811:55 amRNSPurchase of Shares
28th Aug 20187:00 amRNSRegarding Press Speculation
22nd Aug 20183:30 pmRNSSale of Shares
20th Aug 20187:02 amRNSBusiness Update
20th Aug 20187:00 amRNSHalf-year Report - Part 2
20th Aug 20187:00 amRNSHalf-year Report - Part 1
11th Jul 201812:47 pmRNSNotice of Half Year Results
28th Jun 20184:32 pmRNSResult of AGM
27th Jun 20189:29 amRNSTotal Voting Rights
25th Jun 20182:24 pmRNSNotification of Major holding
12th Jun 20183:37 pmRNSExercise of options and sale of shares
12th Jun 20183:35 pmRNSExercise of share options
11th Jun 20187:00 amRNSAgreement
25th May 201810:56 amRNSAGM and Dividend Timetable
21st May 20183:05 pmRNS2017 Annual Report published
10th May 201810:48 amRNSHolding(s) in Company
3rd May 20185:19 pmRNSDirector/PDMR Shareholding
3rd May 20185:16 pmRNSHolding(s) in Company
2nd May 20185:09 pmRNSDirector/PDMR Shareholding
30th Apr 20184:10 pmRNSTotal Voting Rights
30th Apr 20182:12 pmRNSBlock listing Interim Review
30th Apr 20182:12 pmRNSBlock listing Interim Review
26th Apr 201812:59 pmRNSHolding(s) in Company
23rd Apr 20186:25 pmRNSPlacement of USD 450 million bonds
23rd Apr 20187:00 amRNSOffering of USD 450 million bonds
29th Mar 20183:18 pmRNSSale of Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.